Terns Pharmaceuticals, Inc. (TERN) — Biotechnology. Numbers-first dossier: valuation, distress risk, calibrated signal.

How we compute this

TERNpeers & supply-chain relationships

TERN earnings history

Qtick
Sign in
Bid — × — AskUpdated not on fileVol 6.33M · 3-mo avg 5.92M

Terns Pharmaceuticals, Inc. (TERN)

TERNTerns Pharmaceuticals, Inc.loading…
loading…
QTick signal
+1net
1 bull / 1 bear factors · balanced
Bull 3 pts·Bear 2 pts30d
loading…
Market context—Sector read · not on file—Balance sheet · not on file—PCE inflation days · not on file—Knife guard · not on file
Smart entry
—
model abstained · delisted
Target exit
—
model abstained · delisted
Implied move · 1 wk
—
not on file
Chart pattern
—
not on file
Pullback risk
In line
1.00× the norm · 79% saw a ≥10% dip · 63d
Chart pattern
—
not on file
Volume vs its own 20-session averagenot on file
52-week range$2.66 – $53.19
Below high sincenot on file
Risk / reward—
Plan stop—
Max pain—
RSI 1485.7 overbought
Forensic flags0 clean
Earnings multiplen.m. — no profit expected
P/E vs its own pastnot on file
Free cash flow yield-1.3% · burning cash

Entry strategy · 10 triggers

0 of 6 evaluable
RSI 14
●
85.7
overbought
vs 50-day
●
—
not on file
Bollinger
●
—
not on file
VWAP 20
●
—
not on file
Entry level
●
—
not on file
Put wall
●
—
not on file
MACD
Context●
-0.27
below zero · rising toward the flip
RVolStatic
—
not on file
Short int.Static
7.0%
short interest below 20%
ATRStatic
—
not on file
A checklist, not odds on a return: with only 0 usable price conditions there is nothing to line up. RSI, the 50-day average and the Bollinger band move with the price you set; the 20-day average traded price, the entry level and the busiest put strike stay fixed. MACD, RVol, Short int. and ATR are context only — they never count toward the total.
See the full case→
Next earnings
—
not on file
Next dividend
No indicated yield
no forward dividend on file